View source for Yu Baofa

{{short description|Oncologist (b. 1958)}}
{{multiple issues|
{{COI|date=March 2019}}
{{BLP primary sources|date=March 2019}}
}}
{{family name hatnote|Yu|lang=Chinese}}
{{Infobox medical person
| honorific_prefix  = Dr.
| name              = Yu Baofa
| image             =
| image_size        =
| alt               =
| caption           =
| birth_name        = <!-- only use if different from name above -->
| birth_date        = {{birth year and age|1958}}
| birth_place       = [[Jinan]], [[China]]
| death_date        = <!-- {{Death date and age|YYYY|MM|DD|YYYY|MM|DD}} (death date then birth date)  -->
| death_place       =
| death_cause       =
| nationality       = [[Chinese people|Chinese]]
| citizenship       =
| education         = [[Binzhou Medical College]], [[Peking Union Medical College]]
| occupation        = [[Oncologist]]
| years_active      =
| known_for         =
| relations         =
| website           = {{url|http://www.baofatherapy.com}}
| profession        =
| field             =
| work_institutions =
| specialism        =
| research_field    = Intratumoral Cancer Therapy
| notable_works     = Ultra Minimum Incision Personalized Intra-Tumoral Chemo-Immuno (UMIPIC) Therapy.
| prizes            =
| child             =
}}
'''Yu Baofa''' ({{zh|s=于保法|p=Yú Bǎofǎ}}; born in 1958) is a Chinese [[oncologist]] and researcher in [[intratumoral cancer therapy]] and drug development.<ref name="baofa">{{cite web |title=Professor devoted to medical research and treatmentn |url=http://www.chinadaily.com.cn/epaper/html/cd/2003/200303/20030307/20030307010_4.html |website=www.chinadaily.com.cn |access-date=3 March 2019}}</ref> He is the Founder, CEO and Chairman of Baofa Cancer Hospital Network China in Jinan, Beijing and Dongping.<ref name="baofa4">{{cite web |title=Meet Dr. Baofa Yu |url=https://www.baofatherapy.com/meet-dr-baofa-yu |website= Baofa Immunotherapy, LLC. |access-date=3 March 2019 |language=en}}</ref> He also developed Ultra Minimum Incision Personalized Intra-Tumoral Chemo-Immuno (UMIPIC) Therapy.<ref>{{cite journal |last1=Yu |first1=Baofa |last2=Lu |first2=Yuanfei |last3=Gao |first3=Feng |last4=Jing |first4=Peng |last5=Wei |first5=Han |last6=Zhang |first6=Peicheng |last7=Liu |first7=Guoliang |last8=Ru |first8=Ning |last9=Cui |first9=Guanghui |last10=Xu |first10=Xinhai |last11=Sun |first11=Chenglin |last12=Guan |first12=Changjiang |last13=Che |first13=Yebing |last14=Wu |first14=Yingli |last15=Ma |first15=Zhenlu |last16=Fu |first16=Qiang |last17=Liu |first17=Jian |last18=Wang |first18=Huan-You |title=Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy |journal= Lung Cancer: Targets and Therapy|volume=6 |pages=1–11 |doi=10.2147/LCTT.S70679 |pmid=28210146 |pmc=5217516 |date=2015 |doi-access=free }}</ref><ref>{{cite journal |last1=Gao |first1=Feng |last2=Jing |first2=Peng |last3=Liu |first3=Jian |last4=Lu |first4=Yuanfei |last5=Zhang |first5=Peicheng |last6=Han |first6=Wei |last7=Liu |first7=Guoliang |last8=Ru |first8=Ning |last9=Cui |first9=Guanghui |last10=Sun |first10=Chenglin |last11=Che |first11=Yebing |last12=Zhang |first12=Huaming |last13=Hu |first13=Qnglong |last14=Wang |first14=Huan-You |last15=Wu |first15=Yingli |last16=Guan |first16=Changjiang |last17=Fu |first17=Qiang |last18=Ma |first18=Zhenlu |last19=Yu |first19=Baofa |title=Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy |journal= Journal of Hepatocellular Carcinoma|volume=2 |pages=57–68 |doi=10.2147/JHC.S80756 |pmid=27508195 |pmc=4918285 |date=2015 |doi-access=free }}</ref>
== Early life and education ==
Yu was born in 1958 in [[Jinan]], Shandong, China. During his childhood, the local doctors he saw in his village inspired him to become a physician in the future. He was educated in [[Binzhou Medical College]]. Four years later, he graduated and landed a job in the Shandong Tumor Research Institute and transferred to the China Academy of Medical Sciences for further studies in cancer.<ref name=baofa/>
In 1984, his mother was diagnosed with [[esophageal cancer]] and later died. Soon after, his best friend's father died of cancer as well. These experiences motivated him to deepen his research of cancer.<ref name=baofa/>
In 1985, Yu enrolled in [[Peking Union Medical College]] (tumour department) in Beijing to further his studies and received a master's degree of Medicine. After graduation, he worked at the China-Japan Friendship Hospital in Beijing for a year, before attending the School of Medicine of [[University of California, San Diego]] for doctoral studies.<ref name=baofa/>
== Career ==
* In February 1990, Yu performed research on anti-cancer medicines and intratumoral therapy. It was at the time he researched on drug [[slow-release system therapy]] (SRST).<ref name=baofa/>
*
* In 1992, Yu joined the [[Salk Institute]] in [[La Jolla]], [[California]] as Senior Associate Researcher for tumour and cancer genes. A year later, he was appointed as Associate Professor at the [[University of California]], [[San Diego]].<ref name=baofa/>
*
* In 1998, he returned to China and founded the [[TaiMei Baofa Cancer Hospital]] in [[Dongping County|Dongping]], China.<ref name=baofa/>
*
* In 2003, Yu was elected as the deputy of the 10th National People's Congress.<ref name=baofa/>
*
* At present, he is the CEO of Immuno Oncology Systems (IOS) & Baofa Therapy Inc.<ref name=baofa4/>
== Hospitals ==
[[Taimei Baofa Cancer Hospital]] was the first hospital established among three of Dr. Yu's hospitals. Since 1997, it has raised 38 million yuan (US$4.6 million). Yu also invited experts from [[Beijing]] and [[Jinan]] to offer training to his medical staff occasionally.<ref name="baofa2">{{cite web|url=http://www.chinadaily.com.cn/epaper/html/cd/2003/200303/20030307/20030307010_1.html|title=Hospital offers service to cancer patients {{!}} chinadaily.com.cn|website=www.chinadaily.com.cn|access-date=3 March 2019}}</ref>
His hospitals utilize various cancer treatments including surgery, [[Radiation therapy|radiotherapy]], [[biological therapy]], UMIPIC, as well as traditional Chinese medical treatments.<ref name=baofa2/>
== Awards ==
* 2006- China Youth Volunteer Action Contribution Award<ref>{{Cite web|url=http://www.baofayiliao.com/en/proview-17.html|title=China Youth Volunteer Action Contribution Award - Shandong Baofa Oncotherapy Corporation Limited|website=www.baofayiliao.com|access-date=2019-03-06}}</ref>
* 2005- First overseas Chinese "Outstanding Entrepreneurship Award"<ref>{{Cite web|url=http://www.baofayiliao.com/en/proview-15.html|title=Professor Yu Baofa won the first overseas Chinese "Outstanding Entrepreneurship Award" - Shandong Baofa Oncotherapy Corporation Limited|website=www.baofayiliao.com|access-date=2019-03-06}}</ref>
== Patents ==
*{{cite web |title=US Patent for Compositions and methods for targeting of treating neoplasms Patent (Patent # 9,000,036 issued April 7, 2015) - Justia Patents Search |url=https://patents.justia.com/patent/9000036 |website=patents.justia.com |access-date=3 March 2019}}
*{{cite web |title=US Patent Application for COMPOSITIONS AND METHODS FOR TARGETING OF TREATING NEOPLASMS Patent Application (Application #20140037695 issued February 6, 2014) - Justia Patents Search |url=https://patents.justia.com/patent/20140037695 |website=patents.justia.com |access-date=3 March 2019}}
*{{cite web |title=US Patent for Targeting cancer therapy combination Patent (Patent # 8,501,243 issued August 6, 2013) - Justia Patents Search |url=https://patents.justia.com/patent/8501243 |website=patents.justia.com |access-date=3 March 2019}}
*{{cite web |title=US Patent for Combinations and methods for treating neoplasms Patent (Patent # 7,927,612 issued April 19, 2011) - Justia Patents Search |url=https://patents.justia.com/patent/7927612 |website=patents.justia.com |access-date=3 March 2019}}
*{{cite web |title=US Patent Application for COMPOSITION AND METHOD FOR TREATING TUMOR Patent Application (Application #20100104660 issued April 29, 2010) - Justia Patents Search |url=https://patents.justia.com/patent/20100104660 |website=patents.justia.com |access-date=3 March 2019}}
*{{cite web |title=US Patent Application for Combinations and methods for treating neoplasms Patent Application (Application #20050118187 issued June 2, 2005) - Justia Patents Search |url=https://patents.justia.com/patent/20050118187 |website=patents.justia.com |access-date=3 March 2019}}
*{{cite web |title=US Patent for Combinations and methods for treating neoplasms Patent (Patent # 6,811,788 issued November 2, 2004) - Justia Patents Search |url=https://patents.justia.com/patent/6811788 |website=patents.justia.com |access-date=3 March 2019}}
*{{cite web |title=US Patent Application for Combinations and methods for treating neoplasms Patent Application (Application #20020044919 issued April 18, 2002) - Justia Patents Search |url=https://patents.justia.com/patent/20020044919 |website=patents.justia.com |access-date=3 March 2019}}
== Publications ==
*{{cite journal |title=Hapten-enhanced personalized chemoimmunotherapy by intratumoral drug delivery in advanced pancreatic cancer |journal=Journal of Clinical Oncology|volume=32|issue=3 suppl|pages=333|doi=10.1200/jco.2014.32.3_suppl.333|year=2014 |last1=Yu |first1=Baofa |last2=Lu|first2=Yuanfei}}
*{{cite journal |title=Intensity modulation of chemoimmunotherapy for late stages of liver carcinoma|issue=15 suppl |pages=e14716 |journal=Journal of Clinical Oncology |volume=30 |doi=10.1200/jco.2012.30.15_suppl.e14716|date=2012-05-20 |last1=Yu |first1=Baofa |last2=Ma |first2=Zhenlu |last3=Guan |first3=Changjiang |last4=Han |first4=Wei |last5=Che |first5=Yebin |last6=Fu |first6=Qiang }}
*{{cite journal |last1=Wang |first1=Gangshi |last2=Chen |first2=Lichan |last3=Yu |first3=Baofa |last4=Zellmer |first4=Lucas |last5=Xu |first5=Ningzhi |last6=Liao |first6=D. Joshua |title=Learning about the Importance of Mutation Prevention from Curable Cancers and Benign Tumors |journal=Journal of Cancer |volume=7 |issue=4 |pages=436–445 |doi=10.7150/jca.13832 |pmid=26918057 |pmc=4749364 |date=28 January 2016}}
*{{cite journal |last1=Ma |first1=Yukui |last2=Jia |first2=Yuping |last3=Chen |first3=Lichan |last4=Ezeogu |first4=Lewis |last5=Yu |first5=Baofa |last6=Xu |first6=Ningzhi |last7=Liao |first7=D. Joshua |title=Weaknesses and Pitfalls of Using Mice and Rats in Cancer Chemoprevention Studies |journal=Journal of Cancer |volume=6 |issue=10 |pages=1058–1065 |doi=10.7150/jca.12519 |pmid=26366220 |pmc=4565856 |date=1 September 2015}}
*{{cite journal |last1=Gao |first1=Feng |last2=Jing |first2=Peng |last3=Liu |first3=Jian |last4=Lu |first4=Yuanfei |last5=Zhang |first5=Peicheng |last6=Han |first6=Wei |last7=Liu |first7=Guoliang |last8=Ru |first8=Ning |last9=Cui |first9=Guanghui |last10=Sun |first10=Chenglin |last11=Che |first11=Yebing |last12=Zhang |first12=Huaming |last13=Hu |first13=Qnglong |last14=Wang |first14=Huan-You |last15=Wu |first15=Yingli |last16=Guan |first16=Changjiang |last17=Fu |first17=Qiang |last18=Ma |first18=Zhenlu |last19=Yu |first19=Baofa |title=Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy |journal= Journal of Hepatocellular Carcinoma|volume=2 |pages=57–68 |doi=10.2147/JHC.S80756 |pmid=27508195 |pmc=4918285 |date=2015 |doi-access=free }}
*{{cite journal |last1=Yu |first1=Baofa |last2=Lu |first2=Yuanfei |last3=Gao |first3=Feng |last4=Jing |first4=Peng |last5=Wei |first5=Han |last6=Zhang |first6=Peicheng |last7=Liu |first7=Guoliang |last8=Ru |first8=Ning |last9=Cui |first9=Guanghui |last10=Xu |first10=Xinhai |last11=Sun |first11=Chenglin |last12=Guan |first12=Changjiang |last13=Che |first13=Yebing |last14=Wu |first14=Yingli |last15=Ma |first15=Zhenlu |last16=Fu |first16=Qiang |last17=Liu |first17=Jian |last18=Wang |first18=Huan-You |title=Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy |journal= Lung Cancer: Targets and Therapy|volume=6 |pages=1–11 |doi=10.2147/LCTT.S70679 |pmid=28210146 |pmc=5217516 |date=2015 |doi-access=free }}
*{{cite journal |last1=Bu |first1=Jieqiong |last2=Yu |first2=Baofa |title=Slow intra-tumor release od drugs on B16 melonoma in Mice |journal=Journal of Shandong University (Health Sciences) |date=Oct 2007 |volume=45 |pages=988–91 }}
*{{cite journal|last1=Yu|first1=Baofa|last2=Yan|first2=Han|last3=Guoliang|first3=Liu|date=2003|title=Animal Experiment of Introtumoral Drug(ARA-C) Slow Release Depot Therapy.|journal=Journal of Shandong University (Health Science) |volume=41 |issue=Suppl|pages=1–3}}
*{{cite journal |last1=Yu |first1=Baofa |last2=Ma |first2=Zhenlu |last3=Guan |first3=Changjiang |title=Clinical Application of Drug Slow Release Depot Therapy in 780 patterns with malignant |journal=Journal of Shandong University (Health Science) |date=2003  |volume=41 |issue=Suppl|pages=14–18 }}
*{{cite journal |last1=Hui |first1=Li |last2=Cha |first2=Yebin |last3=Liu |first3=Guoliang |last4=Yu |first4=Baofa |title=Slow Release Depot Therapy for 10 patients with advanced or recurrent bladder carcinomas |journal=Journal of Shandong University (Health Science) |date=2003  |volume=41 |issue=Suppl|pages=4–6 }}
*{{cite journal |last1=Yu |first1=Baofa |last2=Lepage |first2=Richard |last3=Wang |first3=Yan |last4=D'Agostino |first4=Horacio |last5=Rice |first5=Roger |last6=Kim |first6=Sinil |title=Spatial Distribution and Pharmacokinetics of free drug and liposomal drug after intratumoral injection |journal=Journal of QiLu Oncology |date=1995 |volume=2 |issue=4 }}
*{{cite journal |last1=Yu |first1=Baofa |last2=Kim |first2=Sinil |title=Achohole With Intratumoral Drug Injection and Pharmacokinetics of Drug After Intratumoral Injection: A New Concept of Intratumoral therapeutic Coagulum With Drug Depots |journal=Journal of Current Oncology |date=1994 |volume=1 |issue=2 |pages=97–100 }}
*{{cite journal |last1=Sharma |first1=Prem Mohini |last2=Bowman |first2=Marianne |last3=Yu |first3=Bao-Fa |last4=Sukumar |first4=Saraswati |title=A Rodent Model for Wilms Tumors: Embryonal Kidney Neoplasms Induced by N-Nitroso-N'-Methylurea |journal=Proceedings of the National Academy of Sciences of the United States of America |date=1994 |volume=91 |issue=21 |pages=9931–9935 |issn=0027-8424|jstor=2365736 |doi=10.1073/pnas.91.21.9931 |pmid=7937920 |bibcode=1994PNAS...91.9931S |pmc=44931 |doi-access=free }}
*{{cite journal |last1=Yu |first1=Baofa |last2=Zhu |first2=Guohon |last3=Tan |first3=Jin |last4=Liu |first4=Lin |last5=Yu |first5=Zehou |last6=Liu |first6=Xifan |last7=Zhu |first7=Jun |last8=Chen |first8=Li |title=Preliminary Clinical Application of Bone Marrow Imaging Using Tc-99m Polyphase liposomes in the malignant lymphoma |journal=Chinese Journal of Oncology |date=1990 |volume=12 |issue=4 |pages=297–300 }}
*{{cite journal |last=Yu |first=Baofa |title=A new bone marrow imaging agent: preparation of sup 99m Tc-polyphase liposomes and its animals experiment |url=https://www.osti.gov/etdeweb/biblio/6258069 |journal=Chinese Journal of Nuclear Medicine |date=August 1989 |volume=9 |issue=3 |pages=167–168}}
*{{cite journal |last1=Yu |first1=Baofa |last2=Tan |first2=Jin |last3=Liu |first3=Lin |last4=Wang |first4=Yan |last5=Zhang |first5=Yumeng |last6=Yong |first6=YongQun |last7=Gu |first7=Xeuqiu |last8=Gu |first8=Maoyu |title=Animal experiment using 99mTc labelled polyphase liposome and application of the radio-imaging with 99mTc-polyphase liposome |journal=Journal of Shenyan College of Pharmacy |date=1988 |volume=5 |issue=1 |pages=1–8 }}
*{{cite journal |last1=Yu |first1=Baofa |last2=Lou |first2=Qin |last3=Liu |first3=Lin |last4=Tan |first4=Jin |title=A new lymph node imaging agent: Tc-99m labelled liposomes and animal experiment |journal=Chinese Journal of Oncology |date=1988 |volume=10 |issue=4 |pages=270–273 }}
== References ==
{{Reflist}}
== External links ==
* [http://www.baofatherapy.com Baofa Therapy.com]
* [http://www.UMIPIC.com Baofa UMIPIC Therapy]
* [http://www.baofayiliao.com/en/ Shandong Baofa Oncotherapy Corporation Limited]
* [http://www.beijingcancer.com/ Beijing BaoFa Tumour Hospital]
{{DEFAULTSORT:Yu, Baofa}}
[[Category:1958 births]]
[[Category:Living people]]
[[Category:Chinese oncologists]]
[[Category:Cancer researchers]]
[[Category:China Zhi Gong Party politicians]]
[[Category:People from Jinan]]
[[Category:Scientists from Shandong]]
[[Category:Peking Union Medical College alumni]]
[[Category:University of California, San Diego faculty]]
[[Category:Physicians from Shandong]]
[[Category:Delegates to the 10th National People's Congress]]
[[Category:21st-century Chinese physicians]]